-Arul M Chinnaiyan Researcher Activity Profile

Research Author Detailed Information 

Arul M Chinnaiyan Publication Rate By Year

Arul M Chinnaiyan has published 5 paper(s) in 2006, 24 paper(s) in 2007, 11 paper(s) in 2008, for a total of 40 research publications in total.

Arul M Am Chinnaiyan Author Information

LAST NAME: chinnaiyan

FIRST NAME: Arul M

INITIALS: am

AFFILIATION:

Papers

Arul M Chinnaiyan's Publication Record

1. Autoantibody profiles reveal ubiquilin 1 as a humoral immune response target in lung adenocarcinoma. Year Published: 2007
Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA.
2. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Year Published: 2007
Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
3. Feature selection and molecular classification of cancer using genetic programming. Year Published: 2007
Bioinformatics Program, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
4. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Year Published: 2006
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, EBRC 442A, 221 Longwood Avenue, Boston, MA 02115-6110, USA.
5. Molecular markers of prostate cancer. Year Published: 2006
Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
6. CD95 (APO-1/Fas)-associating signalling proteins. Year Published: 2006
German Cancer Research Center, Tumor Immunology Program, Heidelberg, Germany.
7. Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cells. Year Published: 2006
Department of Chemistry, Cleveland State University, Euclid Avenue at East 24th Street, Cleveland, OH 44115, USA.
8. Integrative molecular concept modeling of prostate cancer progression. Year Published: 2006
Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
9. Empirical Bayes identification [correction of identication] of tumor progression genes from microarray data. Year Published: 2007
Department of Biostatistics, University of Michigan, 1420 Washington Heights, Ann Arbor, Michigan 48109-2029, USA. ghoshd@umich.edu
10. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Year Published: 2007
Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109-0940, USA.
11. Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model. Year Published: 2007
Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115-6110, USA.
12. Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity. Year Published: 2007
Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, MI 48109, USA.
13. Morphological features of TMPRSS2-ERG gene fusion prostate cancer. Year Published: 2007
Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115-6110, USA.
14. Integrating biomedical knowledge to model pathways of prostate cancer progression. Year Published: 2007
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
15. The lethal phenotype of cancer: the molecular basis of death due to malignancy. Year Published: 2007
Internal Medicine and Urology, University of Michigan, Ann Arbor, MI, USA.
16. A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Year Published: 2007
Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA.
17. Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: molecular evidence for an independent group of diseases. Year Published: 2007
Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
18. Integrative analysis of genomic aberrations associated with prostate cancer progression. Year Published: 2007
Michigan Center for Translational Pathology, Department of Pathology, Department of Urology, Program of Bioinformatics, and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109-0940, USA.
19. The registry case finding engine: an automated tool to identify cancer cases from unstructured, free-text pathology reports and clinical notes. Year Published: 2007
Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI 48109-0942, USA. hanauer@umich.edu
20. Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer. Year Published: 2007
Department of Pathology, Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
21. A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. Year Published: 2007
Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.
22. Integrative biology of prostate cancer progression. Year Published: 2007
Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA. tomlinss@med.umich.edu
23. Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Year Published: 2007
Departments of Dermatology and Internal Medicine, Comprehensive Cancer Center, and Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109.
24. Integrating biomedical knowledge to model pathways of prostate cancer progression. Year Published: 2007
Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
25. Integrative biology of prostate cancer progression. Year Published: 2007
Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA. tomlinss@med.umich.edu
26. Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Year Published: 2007
Department of Dermatology, Comprehensive Cancer Center, and Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA.
27. Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer. Year Published: 2007
Department of Pathology, Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
28. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Year Published: 2008
Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0602, USA.
29. [In Process Citation] Year Published: 2007
30. A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival. Year Published: 2008
Bioinformatigram, The University of of Michigan Medical Center, Ann Arbor, MI 48109 USA.
31. Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition. Year Published: 2007
Department of Dermatology, Comprehensive Cancer Center, and Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, MI 48109, USA.
32. A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival. Year Published: 2008
Bioinformatigram, The University of of Michigan Medical Center, Ann Arbor, MI 48109 USA.
33. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Year Published: 2008
Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109-0602, USA.
34. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Year Published: 2008
Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109-0602, USA.
35. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Year Published: 2008
Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0602, USA.
36. A latent variable approach for meta-analysis of gene expression data from multiple microarray experiments. Year Published: 2008
Department of Statistics and Huck Institute for Life Sciences, Penn State University, University Park, PA, USA. hwchoi@umich.edu
37. Role of the TMPRSS2-ERG Gene Fusion in Prostate Cancer,. Year Published: 2008
Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109.
38. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Year Published: 2008
Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA.
39. Inhibition of CCN6 (Wnt-1-Induced Signaling Protein 3) Down-Regulates E-Cadherin in the Breast Epithelium through Induction of Snail and ZEB1. Year Published: 2008
University of Michigan Medical School, Department of Pathology, 3510C MSRB1, 1150 W. Medical Center Dr., Ann Arbor, MI 48109-0605. kleer@umich.edu.
40. Humoral response profiling reveals pathways to prostate cancer progression. Year Published: 2008
Michigan Center for Translational Pathology, Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.